He stated this, answering questions from the audience.

Earlier, the Ministry of Health of Russia issued the N.N. Gamaleya permission to conduct post-marketing studies of the COVID-19 vaccine.

The director of the Gamaleya Center, Alexander Gintsburg, also noted that the civil circulation of the COVID-19 vaccine could begin a month after the start of the third, post-registration stage of drug research.

Virologist, Doctor of Medical Sciences Anatoly Altstein, in an interview with the NSN, spoke about possible options for the development of the situation with COVID-19.